awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36903127-A7563354-FE14-49B9-9365-9530104800E4
Q36903127-A7563354-FE14-49B9-9365-9530104800E4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36903127-A7563354-FE14-49B9-9365-9530104800E4
Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?
P2860
Q36903127-A7563354-FE14-49B9-9365-9530104800E4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36903127-A7563354-FE14-49B9-9365-9530104800E4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e8447f6a13c022aec50a212cdb649c8ccc6b4d73
P2860
HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data.